These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 27663307

  • 1. [Efficacy and safety of flibanserin "new female Viagra®?": Literature review].
    Terrier C, Terrier JE.
    Prog Urol; 2016; 26(11-12):592-599. PubMed ID: 27663307
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.
    Gao Z, Yang D, Yu L, Cui Y.
    J Sex Med; 2015 Nov; 12(11):2095-104. PubMed ID: 26745616
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
    Katz M, DeRogatis LR, Ackerman R, Hedges P, Lesko L, Garcia M, Sand M, BEGONIA trial investigators.
    J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
    [Abstract] [Full Text] [Related]

  • 4. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
    Portman DJ, Brown L, Yuan J, Kissling R, Kingsberg SA.
    J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
    [Abstract] [Full Text] [Related]

  • 5. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
    Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T, Sand M, Pyke R.
    J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
    Jaspers L, Feys F, Bramer WM, Franco OH, Leusink P, Laan ET.
    JAMA Intern Med; 2016 Apr; 176(4):453-62. PubMed ID: 26927498
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
    Simon JA, Thorp J, Millheiser L.
    J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
    [Abstract] [Full Text] [Related]

  • 10. Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis.
    Kamrul-Hasan ABM, Hannan MA, Alam MS, Aalpona FTZ, Nagendra L, Selim S, Dutta D.
    Medicine (Baltimore); 2024 Jun 21; 103(25):e38592. PubMed ID: 38905407
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial.
    Simon JA, Kingsberg SA, Shumel B, Hanes V, Garcia M, Sand M.
    Menopause; 2014 Jun 21; 21(6):633-40. PubMed ID: 24281236
    [Abstract] [Full Text] [Related]

  • 12. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.
    Thorp J, Simon J, Dattani D, Taylor L, Kimura T, Garcia M, Lesko L, Pyke R, DAISY trial investigators.
    J Sex Med; 2012 Mar 21; 9(3):793-804. PubMed ID: 22239862
    [Abstract] [Full Text] [Related]

  • 13. Systematic Review and Meta-analysis of Flibanserin's Effects and Adverse Events in Women with Hypoactive Sexual Desire Disorder.
    Saadat SH, Kabir A, Rahmani K, Panahi Y, Hosseinialhashemi M, Sahebkar A.
    Curr Drug Metab; 2017 Mar 21; 18(1):78-85. PubMed ID: 27784209
    [Abstract] [Full Text] [Related]

  • 14. Open-label extension study of flibanserin in women with hypoactive sexual desire disorder.
    Jayne C, Simon JA, Taylor LV, Kimura T, Lesko LM, SUNFLOWER study investigators.
    J Sex Med; 2012 Dec 21; 9(12):3180-8. PubMed ID: 23057791
    [Abstract] [Full Text] [Related]

  • 15. Flibanserin and its discontents.
    Aftab A, Chen C, McBride J.
    Arch Womens Ment Health; 2017 Apr 21; 20(2):243-247. PubMed ID: 27858170
    [Abstract] [Full Text] [Related]

  • 16. Flibanserin: From Bench to Bedside.
    Dooley EM, Miller MK, Clayton AH.
    Sex Med Rev; 2017 Oct 21; 5(4):461-469. PubMed ID: 28757356
    [Abstract] [Full Text] [Related]

  • 17. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
    Dhanuka I, Simon JA.
    Expert Opin Pharmacother; 2015 Oct 21; 16(16):2523-9. PubMed ID: 26395164
    [Abstract] [Full Text] [Related]

  • 18. Ignorance Is Not Bliss: If We Don't Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary.
    Anderson R, Moffatt CE.
    J Sex Med; 2018 Mar 21; 15(3):273-283. PubMed ID: 29396022
    [Abstract] [Full Text] [Related]

  • 19. Flibanserin Efficacy and Safety in Premenopausal Women With Generalized Acquired Hypoactive Sexual Desire Disorder.
    Fisher WA, Pyke RE.
    Sex Med Rev; 2017 Oct 21; 5(4):445-460. PubMed ID: 28666836
    [Abstract] [Full Text] [Related]

  • 20. Weight Loss in Women Taking Flibanserin for Hypoactive Sexual Desire Disorder (HSDD): Insights Into Potential Mechanisms.
    Simon JA, Kingsberg SA, Goldstein I, Kim NN, Hakim B, Millheiser L.
    Sex Med Rev; 2019 Oct 21; 7(4):575-586. PubMed ID: 31196764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.